Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 27 Apr 2023
In the second week of life, 83 percent of newborns who were fed formula milk had Clostridium difficile and Clostridium perfringens, but by the end of the third week, all infants had these infections.
Read Full NewsFor men with intermediate-risk prostate cancer, SBRT may beat longer-course radiotherapy in some measures of quality of life, but not disease-free survival.
Weekly electronic symptom monitoring was associated with improved fatigue and physical functioning in a randomized trial of patients with metastatic breast cancer.
Outcomes improve when a novel, first-in-class immunomodulatory drug is combined with daratumumab and dexamethasone in previously treated patients.
1.
Pulled Myeloma Drug Improves Survival in Trial
2.
AZD0486 Shows Good Efficacy in Relapsed/Refractory Follicular Lymphoma
3.
OA Tied to Arthritis AE Risk in ICI-Treated Patients
4.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
5.
Can Concurrent Boost Safely Shorten Breast Cancer Radiation?
1.
Transformative Directions in Hematology in Clinical Decision-Making
2.
Surgical Innovation Using Tumor-Adaptive Surgical Resection Strategies
3.
Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications
4.
What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder
5.
Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge